- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05048823
Osteopathic Bowel Techniques and Their Effects on the Autonomic Nervous System in Healthy Individuals
March 12, 2024 updated by: Instituto Docusse de Osteopatia e Terapia Manual
Osteopathic Bowel Techniques and Their Effects on the Autonomic Nervous and Pain Pressure Sensitivity: Randomized Clinical Trial
INTRODUCTION: The autonomic nervous system (ANS) is responsible for controlling several visceral functions, including the motility and secretion of the gastrointestinal system (GIS).
Alterations in the functioning of the ANS can directly influence the physiological mechanisms of the GIS.
Due to the importance of the ANS in the control of various body functions, strategies aimed at acting in this system have become extremely important and have been widely used in the literature.
Some of the studies involving ANS analysis have shown that osteopathic manipulative treatment is able to promote a reduction in sympathetic ANS activity and an increase in parasympathetic ANS activity in asymptomatic youngsters, however, none of them addressed the GIS, already known to be influenced by autonomic fibers.
OBJECTIVE: To evaluate the immediate effects of GIS-directed osteopathic techniques on ANS behavior and pain sensitivity to pressure in young people without symptoms of gastrointestinal disorders.
METHODS: The present study is characterized by a randomized, single-blind clinical trial, in which 42 asymptomatic individuals will be recruited, regardless of gender, aged between 18 and 30 years.
Volunteers will be randomly distributed into two groups called intervention protocol and placebo protocol.
The intervention protocol will be performed by a professional with 10 years of clinical experience in the field of Osteopathy and will perform the techniques of Generalized Discharge of the peritoneum and intestinal wings, Mobilization of the Cecum, technique for the Mesentery Root, Release of the D1-D2 angle, technique for the Sigmoid Colon.
The approximate duration of the set of techniques will be 15 minutes with the volunteers positioned supine on a stretcher.
The placebo protocol will apply in the same way regarding the positioning and duration of the techniques.
The therapist will position the hands in the same regions of the intervention protocol, maintaining superficial contact for 3 minutes in each region, without therapeutic intent.
Volunteers will be evaluated for outcomes before and immediately after performing the protocols.
The heart rate variability will be measured by capturing the intervals between each beat in ms, using a heart rate monitor and extracting the linear indices in the domain of time, frequency and geometric heart rate variability.
The pressure pain threshold will also be measured using a pressure algometer that will be positioned in the vertebral region of T5-L3.
Comparisons of variables (indices of HRV and pressure pain threshold) between the intervention protocol group and placebo protocol will be performed using the Student's T test (normal data) or the Mann-Whitney test (non-normal data).
All results will be discussed at the 5% significance level.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Presidente Prudente, São Paulo, Brazil
- Anne Kastelianne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
-Health individuals
Exclusion Criteria:
- Participants with neurological impairment and/or pathologies that interfere with autonomic behavior
- smokers
- diagnosis of pulmonary disease
- Participants with theoretical and/or practical knowledge about the techniques that will be applied in the protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Protocol
Visceral techniques for the gastrointestinal system
|
Generalized Discharge Technique of the Peritoneum and Intestinal Wings, Mobilization of the Cecum, Technique for the Root of the Mesentery, Release of the D1-D2 Angle, Technique for the Sigmoid Colon
|
|
Sham Comparator: Placebo Protocol
simulated visceral techniques in the region of the gastrointestinal system, without therapeutic intent
|
Simulated visceral techniques in the region of the gastrointestinal system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability (HRV)
Time Frame: Immediately after intervention
|
The HRV data will be analyzed using linear methods, analyzed in the time and frequency domains and using geometric indices.
|
Immediately after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure pain threshold
Time Frame: Immediately after intervention
|
Pressure pain threshold will be assessed using a mechanical device (algometer), known to quantify pain intensity at a specific point through local pressure.
The pain threshold will be considered through the minimum pressure necessary to induce pain in the assessed region.
The points evaluated in this study correspond to the thoracic and lumbar levels of T5-L3
|
Immediately after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2021
Primary Completion (Actual)
October 15, 2021
Study Completion (Actual)
October 30, 2021
Study Registration Dates
First Submitted
September 3, 2021
First Submitted That Met QC Criteria
September 8, 2021
First Posted (Actual)
September 17, 2021
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17249119.2.0000.5515
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Will be shared with other researchers when requested
IPD Sharing Time Frame
After one year from publication
IPD Sharing Access Criteria
To request the data, please contact nupi@idot.com.br
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Visceral Osteopathic Techniques
-
Istanbul Rumeli UniversityNot yet recruitingOsteopathic Manipulative Treatment (OMT)Turkey
-
Touro University NevadaCompleted
-
CentraState Medical CenterUnknownMultiple Sclerosis | Overactive Bladder | Urinary Incontinence | Bladder DysfunctionUnited States
-
International Academy of OsteopathyCompleted
-
Beni-Suef UniversityNot yet recruitingOsteopathic Manipulative TreatmentEgypt
-
University of GaziantepRecruitingMultiple Sclerosis | Urinary Incontinence | Pelvic Floor Disorders | Osteopathic Manipulative Treatment | Visceral MobilizationTurkey
-
Laiana Sepúlveda de Andrade MesquitaCompletedBenign Paroxysmal Positional VertigoBrazil
-
University of SorocabaCompleted
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Recruiting
-
Laval UniversityRecruitingFood Preferences | Adiposity | Eating BehaviorCanada